To select suitable cell lines for functional studies, we assessed CBP 50% inhibitory concentration (IC50) values across multiple HNSCC cell lines and found a positive correlation between CBP resistance and PRMT1 expression (Figure S3D, Supporting Information). The gene discussed is PRMT1; the disease is head and neck squamous cell carcinoma.